Information Provided By:
Fly News Breaks for January 8, 2019
BFB, BFA, BF.B
Jan 8, 2019 | 21:39 EDT
Goldman Sachs analyst Judy Hong downgraded Brown-Forman to Sell and lowered her price target for the shares to $43 from $48. The analyst believes whiskey competition in the U.S. and a "more muted" pricing and margin outlook create downside risk to consensus estimates. Competition in U.S. whiskey is causing Jack Daniels to lose market share, Hong tells investors in a research note. Further, Brown-Forman's valuation is still full even after recent stock pullback, the analyst argues.
News For B;BFA;BFB From the Last 2 Days
BFA, BFB
Dec 5, 2019 | 08:56 EST
HIGHER: Nike (NKE), up 2% after Goldman Sachs analyst Alexandra Walvis upgraded the stock to Buy from Neutral with a $112 price target and added the shares to her firm's Americas Conviction List. Nike is on the cusp of a "sharp acceleration" in earnings growth, Walvis tells investors. UP AFTER EARNINGS: Dollar General (DG), up 3%... Express (EXPR), up 13%... RH (RH), up 2%... Signet Jewelers (SIG), up 7%... Five Below (FIVE), up 6%... Slack Technologies (WORK), up 3%. DOWN AFTER EARNINGS: Brown-Forman (BF.B), down 1%... J. Jill (JILL), down 11%... Elastic (ESTC), down 15%... At Home Group (HOME), down 42%. ALSO LOWER: Sage Therapeutics (SAGE), down 62% after announcing its Phase 3 Study evaluating the effect of SAGE-217 on depressive symptoms in adults with major depressive disorder did not meet its primary endpoint of a statistically significant reduction from baseline compared to placebo.